DFSV vs XLV
Dimensional US Small Cap Value ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.31% for DFSV.
Side-by-side metrics
| Metric | DFSV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.31% | 0.08% |
Dividend yield Trailing 12-month yield. | — | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $27.77B | $49.10B |
YTD return | 19.52% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.96 | 0.41 |
P/E ratio | 13.30 | 30.63 |
Last price | $39.35 | $187.94 |
Inception | — | — |
Issuer | Dimensional | State Street |
DFSV top holdings
| DINO | HF Sinclair Corp | 0.88% |
| ARW | Arrow Electronics Inc | 0.82% |
| BWA | BorgWarner Inc | 0.80% |
| AVT | Avnet Inc | 0.80% |
| ELAN | Elanco Animal Health Inc | 0.75% |
| IVZ | Invesco Ltd | 0.74% |
| KNX | Knight-Swift Transportation Holdings Inc Class A | 0.70% |
| OVV | Ovintiv Inc | 0.68% |
| JXN | Jackson Financial Inc | 0.65% |
| SWKS | Skyworks Solutions Inc | 0.65% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About DFSV
DFSV (Dimensional US Small Cap Value ETF) is Systematic small-cap value strategy from Dimensional. Managed by Dimensional, the fund carries $27.8B in assets under management, an expense ratio of 0.31%. Its largest holding is HF Sinclair Corp (DINO), which represents 0.9% of the portfolio. Real Estate is the fund's largest sector exposure at 0.8%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.